about
Role of Astroglial Hemichannels and Pannexons in Memory and Neurodegenerative Diseases[Late-onset depression : Pathophysiology, diagnostics and treatment].Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.Dependency criterion based brain pathological age estimation of Alzheimer's disease patients with MR scansTranslocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative DiseasesAltered Superficial White Matter on Tractography MRI in Alzheimer's Disease.The superior fault tolerance of artificial neural network training with a fault/noise injection-based genetic algorithm.Impaired White Matter Connections of the Limbic System Networks Associated with Impaired Emotional Memory in Alzheimer's Disease.Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV.Neuropsychiatric Symptoms in Alzheimer Disease, Vascular Dementia, and Mixed Dementia.CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer's PSEN2 N141I neurons.Adrenomedullin Contributes to Age-Related Memory Loss in Mice and Is Elevated in Aging Human Brains.Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease.Cognitive Decline in Neuronal Aging and Alzheimer's Disease: Role of NMDA Receptors and Associated Proteins.Global Cerebral Atrophy Detected by Routine Imaging: Relationship with Age, Hippocampal Atrophy, and White Matter Hyperintensities.SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI."Tau immunotherapy: Hopes and hindrances".Enhanced Molecular Aging in Late-Life Depression: the Senescent-Associated Secretory Phenotype.Biomarkers of Cognitive Impairment: Brain Cortical Thickness, Volumetrics, and Cerebrospinal Fluid.Evaluation and clinical correlation of practical cut-offs for visual rating scales of atrophy: normal aging versus mild cognitive impairment and Alzheimer's disease.Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology.Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for AlzheiCognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
P2860
Q26739590-E08FAACF-0D58-479F-ADD8-39DC79CC0840Q31121945-19F21E78-E1B1-42B8-89A2-F1B42F5F36ADQ31153910-9C6B8058-840B-4878-BA52-A59C9E7EE83AQ33601196-A067F08F-9722-4B6E-888D-44B269C583EDQ33624586-EA4AF3A0-160F-4748-AA90-8266BB202BB4Q37122836-E1317B25-12A3-4C47-A49E-0B76768561DFQ37321715-E88F2FBF-A3DF-4AB5-9E61-6FCD1F52EEA9Q37368600-E03E452E-C72E-40FC-AE94-737ADF2FC462Q38639562-53FE041E-D83C-4951-8A9E-A19910AA9907Q38937204-A7BFA0F2-64E2-4B52-965E-A5544B96C68DQ42517607-38952A75-D89A-461F-B17F-F11AC406CDA4Q45406965-9B9289C0-6FF8-454C-A9AA-B956F3884175Q46058400-7F545FDB-E9C9-41AF-BEA6-69607B84CFD0Q47119516-1E31AD78-2D3D-43E2-8E68-A38C0632D3C2Q47190775-691A8E3E-6506-481D-9949-798A3A0C5ADDQ47339115-3FF6A580-06F4-4FE9-A288-30E5BF363DA5Q47629452-FAC8286E-D38E-44E6-B9AC-DF103D99A4EFQ47876260-6AE429B4-BDB0-4CBA-86E4-48657CC027B8Q47943083-5C7A2D73-3507-4B31-9BEB-3B5BFCC0BBDFQ48292968-EDA4BA00-E902-4B9B-94DC-CF2FEFF94144Q51760905-A0387F56-1EDE-4E6D-8726-F10D5DCBE472Q52836541-AE7AD69E-77D6-45CF-A5CE-06802E0FAC71Q55400177-5D3440D5-72C4-4FBB-90A4-EDEF70BE88C7
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Brain atrophy in Alzheimer's Disease and aging.
@ast
Brain atrophy in Alzheimer's Disease and aging.
@en
type
label
Brain atrophy in Alzheimer's Disease and aging.
@ast
Brain atrophy in Alzheimer's Disease and aging.
@en
prefLabel
Brain atrophy in Alzheimer's Disease and aging.
@ast
Brain atrophy in Alzheimer's Disease and aging.
@en
P2093
P50
P1476
Brain atrophy in Alzheimer's Disease and aging.
@en
P2093
Enrica Cavedo
Giovanni B Frisoni
Samantha Galluzzi
P356
10.1016/J.ARR.2016.01.002
P577
2016-01-28T00:00:00Z